190 related articles for article (PubMed ID: 37500061)
21. An association between Trichomonas vaginalis and high-risk human papillomavirus in rural Tanzanian women undergoing cervical cancer screening.
Lazenby GB; Taylor PT; Badman BS; McHaki E; Korte JE; Soper DE; Young Pierce J
Clin Ther; 2014 Jan; 36(1):38-45. PubMed ID: 24417784
[TBL] [Abstract][Full Text] [Related]
22. Trichomonas vaginalis infection among homeless and unstably housed adult women living in a resource-rich urban environment.
Riley ED; Cohen J; Dilworth SE; Grimes B; Marquez C; Chin-Hong P; Philip SS
Sex Transm Infect; 2016 Jun; 92(4):305-8. PubMed ID: 26347544
[TBL] [Abstract][Full Text] [Related]
23. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.
Meites E; Llata E; Braxton J; Schwebke JR; Bernstein KT; Pathela P; Asbel LE; Kerani RP; Mettenbrink CJ; Weinstock HS
Sex Transm Dis; 2013 Nov; 40(11):865-9. PubMed ID: 24113409
[TBL] [Abstract][Full Text] [Related]
24. The prevalence and risk factors for
Ijasan O; Okunade KS; Oluwole AA
Niger Postgrad Med J; 2018; 25(1):21-26. PubMed ID: 29676341
[TBL] [Abstract][Full Text] [Related]
25. Trichomonas vaginalis is very rare among women with vaginal discharge in Podlaskie province, Poland.
Serwin AB; Bulhak-Koziol V; Sokolowska M; Golparian D; Unemo M
APMIS; 2017 Sep; 125(9):840-843. PubMed ID: 28612378
[TBL] [Abstract][Full Text] [Related]
26. Trends and associations of Trichomonas vaginalis infection in men and women with genital discharge syndromes in Johannesburg, South Africa.
Lewis DA; Marsh K; Radebe F; Maseko V; Hughes G
Sex Transm Infect; 2013 Sep; 89(6):523-7. PubMed ID: 23605850
[TBL] [Abstract][Full Text] [Related]
27. Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: A systematic review and meta-analysis of 470 000 patients.
Hamar B; Teutsch B; Hoffmann E; Hegyi P; Váradi A; Nyirády P; Hunka Z; Ács N; Lintner B; Hermánné RJ; Melczer Z
Int J Gynaecol Obstet; 2023 Oct; 163(1):31-43. PubMed ID: 37010897
[TBL] [Abstract][Full Text] [Related]
28. Perceived stress and incident sexually transmitted infections in a prospective cohort.
Turpin R; Brotman RM; Miller RS; Klebanoff MA; He X; Slopen N
Ann Epidemiol; 2019 Apr; 32():20-27. PubMed ID: 30799204
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Trichomonas vaginalis in women of reproductive age at a family health clinic.
Glehn MP; Sá LC; Silva HD; Machado ER
J Infect Dev Ctries; 2017 Mar; 11(3):269-276. PubMed ID: 28368862
[TBL] [Abstract][Full Text] [Related]
30. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.
Muzny CA; Blackburn RJ; Sinsky RJ; Austin EL; Schwebke JR
Clin Infect Dis; 2014 Sep; 59(6):834-41. PubMed ID: 24928292
[TBL] [Abstract][Full Text] [Related]
31. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention.
Van der Pol B
Clin Infect Dis; 2007 Jan; 44(1):23-5. PubMed ID: 17143810
[No Abstract] [Full Text] [Related]
32. Trichomonas vaginalis infection in Nigerian pregnant women and risk factors associated with sexually transmitted infections.
Oyeyemi OT; Fadipe O; Oyeyemi IT
Int J STD AIDS; 2016 Nov; 27(13):1187-1193. PubMed ID: 26438604
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.
Sutton M; Sternberg M; Koumans EH; McQuillan G; Berman S; Markowitz L
Clin Infect Dis; 2007 Nov; 45(10):1319-26. PubMed ID: 17968828
[TBL] [Abstract][Full Text] [Related]
34. Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands.
de Jong AS; Rahamat-Langendoen JC; van Alphen P; Hilt N; van Herk C; Pont S; Melchers W; van de Bovenkamp J
Int J STD AIDS; 2016 Sep; 27(10):856-60. PubMed ID: 26199286
[TBL] [Abstract][Full Text] [Related]
35. Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection.
Martin DH; Zozaya M; Lillis RA; Myers L; Nsuami MJ; Ferris MJ
J Infect Dis; 2013 Jun; 207(12):1922-31. PubMed ID: 23482642
[TBL] [Abstract][Full Text] [Related]
36. Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually transmitted infection.
Munson E; Kramme T; Napierala M; Munson KL; Miller C; Hryciuk JE
J Clin Microbiol; 2012 Dec; 50(12):3927-31. PubMed ID: 23015673
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria.
Anorlu RI; Fagbenro Beyioku AF; Fagorala T; Abudu OO; Galadanci HS
Niger Postgrad Med J; 2001 Dec; 8(4):183-6. PubMed ID: 11922025
[TBL] [Abstract][Full Text] [Related]
38. Trichomonas vaginalis infection in women who submit self-obtained vaginal samples after internet recruitment.
Gaydos CA; Hsieh YH; Barnes M; Quinn N; Agreda P; Jett-Goheen M; Whittle P; Hogan T
Sex Transm Dis; 2011 Sep; 38(9):828-32. PubMed ID: 21844738
[TBL] [Abstract][Full Text] [Related]
39. Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases.
Pereyre S; Laurier Nadalié C; Bébéar C;
Clin Microbiol Infect; 2017 Feb; 23(2):122.e1-122.e7. PubMed ID: 27836808
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of vaginal infections with bacterial vaginosis, Trichomonas vaginalis and Candida albicans among pregnant women at the Port Moresby General Hospital Antenatal Clinic.
Klufio CA; Amoa AB; Delamare O; Hombhanje M; Kariwiga G; Igo J
P N G Med J; 1995 Sep; 38(3):163-71. PubMed ID: 9522855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
